Clarus Lifesciences III, L.P. Insider Trading $BX Blackstone Group Inc
Get free email notifications about insider trading for Clarus Lifesciences III, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarus Lifesciences III, L.P.. Clarus Lifesciences III, L.P. is 10% Owner in Blackstone Group Inc ($BX) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Forty Seven, Inc. ($FTSV) and 10% Owner in AVROBIO, Inc. ($AVRO) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).
Clarus Lifesciences III, L.P. in Blackstone Group Inc
Trading Symbol: BXIndustry: INVESTMENT ADVICE [6282]
Position of Clarus Lifesciences III, L.P.: 10% Owner
Holdings: 4,859,812 shares
Current Value: $148,467,257
Latest Transaction: May 14 2021
$BX Market Capitalization: $19.27B
$BX Previous Close: $30.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Clarus Lifesciences III, L.P. in Blackstone Group Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANNX, AVRO, BX, ETTX, FTSV, GRAY, GRTS, PRAX, TALS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 135,334 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 676,774 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 366,918 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 562,891 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 278,707 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 696,767 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 717,160 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,586,364 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,944,371 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,982,874 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,476,924 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,692,307 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 26,000,000 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 701 | 11,917 | 160,044 | 159.3 K to 160 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 3,507 | 59,619 | 800,353 | 796.8 K to 800.4 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 1,902 | 32,334 | 433,917 | 432 K to 433.9 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 2,917 | 49,589 | 665,676 | 662.8 K to 665.7 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 1,444 | 24,548 | 329,598 | 328.2 K to 329.6 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 3,611 | 61,387 | 823,997 | 820.4 K to 824 K (+0.44 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 15,918 | 270,606 | 4,875,730 | 4.9 M to 4.9 M (+0.33 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 25,296 | 0 | 159,343 | 134 K to 159.3 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 126,499 | 0 | 796,846 | 670.3 K to 796.8 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 68,582 | 0 | 432,015 | 363.4 K to 432 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 105,213 | 0 | 662,759 | 557.5 K to 662.8 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 52,094 | 0 | 328,154 | 276.1 K to 328.2 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 130,236 | 0 | 820,386 | 690.2 K to 820.4 K (+18.87 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 134,047 | 0 | 134,047 | 0 to 134 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 670,347 | 0 | 670,347 | 0 to 670.3 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 363,433 | 0 | 363,433 | 0 to 363.4 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 557,546 | 0 | 557,546 | 0 to 557.5 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 276,060 | 0 | 276,060 | 0 to 276.1 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 690,150 | 0 | 690,150 | 0 to 690.2 K |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 4,859,812 | 0 | 4,859,812 | 0 to 4.9 M |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 352,734 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,941,748 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 559,208 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,410,477 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,052,852 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,375,799 | 0 | 0 | |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 164,832 | 0 | 7,594,109 | 7.4 M to 7.6 M (+2.22 %) |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 907,378 | 0 | 907,378 | 0 to 907.4 K |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 261,318 | 0 | 7,429,277 | 7.2 M to 7.4 M (+3.65 %) |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 659,116 | 0 | 7,167,959 | 6.5 M to 7.2 M (+10.13 %) |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 2,361,198 | 0 | 6,508,843 | 4.1 M to 6.5 M (+56.93 %) |
Oct 22 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 3,446,711 | 0 | 4,147,645 | 700.9 K to 4.1 M (+491.73 %) |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,109,407 | 0 | 0 | |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,148,147 | 0 | 0 | |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,370,685 | 0 | 0 | |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,666,667 | 0 | 0 | |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 200,000 | 3,400,000 | 2,730,635 | 2.5 M to 2.7 M (+7.90 %) |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 239,433 | 0 | 2,530,635 | 2.3 M to 2.5 M (+10.45 %) |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 697,860 | 0 | 2,291,202 | 1.6 M to 2.3 M (+43.80 %) |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 950,134 | 0 | 1,593,342 | 643.2 K to 1.6 M (+147.72 %) |
Jul 30 2020 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 643,208 | 0 | 643,208 | 0 to 643.2 K |
Page: 1